Nature Communications · 2024 · 47 citations · 27 references
Life SciencesImmunologyMicrobiologyBacteriologyHost-pathogen InteractionsInnate ImmunityAntiviral ImmunityBacterial PathogenesisImmune Responses To InfectionInnate Immune ResponseInnate Immune Signaling PathwaysPathogenesis Of Infectious DiseaseAntiviral Innate SignalingBacteriophage BiologyBacteriophage TherapyHost Antiviral ResponsePhage InfectionPhage-host InteractionsRna Polymerase Iii FunctionSting Pathway
One of the hopes for overcoming the antibiotic resistance crisis is the use of bacteriophages to combat bacterial infections, the so-called phage therapy. This therapeutic approach is generally believed to be safe for humans and animals as phages should infect only prokaryotic cells. Nevertheless, recent studies suggested that bacteriophages might be recognized by eukaryotic cells, inducing specific cellular responses. Here we show that in chickens infected with Salmonella enterica and treated with a phage cocktail, bacteriophages are initially recognized by animal cells as viruses, however, the cGAS-STING pathway (one of two major pathways of the innate antiviral response) is blocked at the stage of the IRF3 transcription factor phosphorylation. This inhibition is due to the inability of RNA polymerase III to recognize phage DNA and to produce dsRNA molecules which are necessary to stimulate a large protein complex indispensable for IRF3 phosphorylation, indicating the mechanism of the antiviral response impairment.
27
P. Jault, Thomas Leclerc, Serge Jennes et al. · The Lancet Infectious Diseases · 2018 · 843 citations · Full text
Expansion of Bacteriophages Is Linked to Aggravated Intestinal Inflammation and Colitis
Lasha Gogokhia, Kate Buhrke, Rickesha Bell et al. · Cell Host & Microbe · 2019 · 606 citations